Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Bevacizumab [USAN:INN]
RN: 216974-75-3
UNII: 2S9ZZM9Q9V

Notes

  • An anti-VEGF recombinant monoclonal antibody consisting of humanized murine antibody. It inhibits VEGF receptors and prevents the proliferation of blood vessels.
  • anti-VEGF monoclonal antibody consisting of humanized murine antibody with antigen-binding, complementary-determining regions from murine VEGF.

Molecular Formula

  • Unspecified
 

Classification Codes

  • Angiogenesis Inhibitors
  • Angiogenesis Modulating Agents
  • Antineoplastic
  • Antineoplastic Agents
  • Growth Inhibitors
  • Growth Substances
  • Monoclonal Antibody

Names and Synonyms

Name of Substance

  • Bevacizumab
  • Bevacizumab [USAN:INN]

MeSH Heading

  • Bevacizumab

Synonyms

  • ABP 215
  • ABP-215
  • Altuzan
  • Anti-VEGF Humanized Monoclonal Antibody
  • Anti-VEGF monoclonal antibody
  • Avastin
  • Bevacizumab
  • Bevacizumab-Awwb
  • Bevacizumab-Awwb [Biosimilar]
  • HSDB 8080
  • Immunoglobulin G 1 (human-mouse monoclonal rhuMAb-VEGF gamma-chain anti-human vascular endothelial growth factor), disulfide with human-mouse monoclonal rhuMAb-VEGF light chain, dimer
  • Mvasi
  • Mvasi [Biosimilar]
  • rhuMAb-VEGF
  • UNII-2S9ZZM9Q9V

Systematic Name

  • Immunoglobulin G1, anti-(human vascular endothelial growth factor) (human-mouse monoclonal rhuMAb-VEGF gamma1-chain), disulfide with human-mouse monoclonal rhuMAb-VEGF light chain, dimer

Registry Numbers

CAS Registry Number

  • 216974-75-3

FDA UNII

  • 2S9ZZM9Q9V

System Generated Number

  • 0216974753